Company / PP&E per Share
Jazz Pharmaceuticals PP&E per Share History
FY2016-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$3.70
FY2022
5-year range
$3.70 / $4.57
FY2018-FY2022
Trend
-19.1%
vs FY2021
Sector context
#21 of 191
Health Care
What the data says
Jazz Pharmaceuticals's pp&e per share of $3.70 is higher than 89% of companies in the Health Care sector (FY2022). PP&E per Share has fluctuated over the past 7 years, ranging from $1.75 in FY2016 to $4.57 in FY2021.
Based on SEC 10-K filings.
3.70 in FY2022 with a 5-year CAGR of +5.4%. Top quartile in the Health Care sector.
Improved from $2.28 to $3.70 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +26.7%
- 5-Year CAGR
- +5.4%
- 10-Year CAGR
- -
Sector benchmark
Top 11% in Health CareTop 11% of 191This company $3.70 Sector average $18.90
▼
-80.4% below sector average
Key checks
Key Insights
- In FY2022, pp&e per share decreased 19.1% year-over-year.
- Ranks #21 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2021.
- Lowest pp&e per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.66 (distress zone, below 1.8 threshold)
- Negative profit margin: -8.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $3.70 | -19.1% |
| FY2021 | $4.57 | +100.6% |
| FY2020 | $2.28 | +25.3% |
| FY2019 | $1.82 | -46.5% |
| FY2018 | $3.40 | +19.6% |
| FY2017 | $2.84 | +62.2% |
| FY2016 | $1.75 | +24.3% |
As of FY2022 · SEC 10-K · Updated Jun 30, 2026